Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 61; no. 4; pp. e90 - e92
Main Authors Okada, Yuri, Izumi, Rumiko, Hosaka, Tatsuhiko, Watanabe, Satoshi, Shijo, Tomomi, Hatchome, Naokazu, Konishi, Risa, Ichimura, Yuki, Okiyama, Naoko, Suzuki, Naoki, Misu, Tatsuro, Aoki, Masashi
Format Journal Article
LanguageEnglish
Published England Oxford University Press 11.04.2022
Subjects
Adenosine Triphosphatases
Autoantibodies
COVID-19 - complications
Dermatomyositis - complications
Dermatomyositis - diagnosis
DNA-Binding Proteins
Humans
Letter to the Editor (Case report)
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Yuri Okada, Rumiko Izumi, Masashi Aoki contributed equally to this work.
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/keab872